The interaction between cancer cells and CAFs can also reduce cytotoxic effects of chemotherapeutic drugs such as cisplatin by cell–cell adhesion through N-cadherin that activates the survival-promoting protein kinase B (PKB)/AKT and blocks pro-apoptotic Bad [402]. Here, AKT1 is linked to cancer.